Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages

Authors: C. Gomez-Roca, Antoîne Italiano, Christophe Le Tourneau, Philippe A. Cassier, Maud Toulmonde, Sandra P. D’Angelo, Mario Campone, Kristy Weber, Delphine Loirat, Michael A. Cannarile, Anna Maria Jegg, Carola H. Ries, R D Christen, Georgina Meneses‐Lorente, Wolfgang Jacob, Irina Klaman, Chia-Huey Ooi, Carl Watson, Kathrin Wonde, Bernhard Reis, Francesca Michielin, Dominik Rüttinger, Jean‐Pierre Delord, Jean‐Yves Blay - Annals of Oncology 2019 cited by 202